Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GT Biopharma, Inc.GTBP · Entity 7878 | Chief Financial Officer | September 04, 2025 | September 08, 2025 |
| Prairie Operating Co.CRKR · Entity 7132 | Chief Financial Officer | December 23, 2021 | January 21, 2022 |
| Research Solutions, Inc.RSSS · Entity 6984 | CFO & Secretary | September 20, 2021 | September 21, 2021 |
| SRAX, Inc.SRAX · Entity 95766 | Chief Financial Officer | March 14, 2023 | March 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GT Biopharma, Inc.
Report date September 04, 2025 · Filed September 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.33 · Expires 2035-08-19 | Direct | 50,000 |
Reported balance
After 2025-09-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-09-04 · Grant · Acquired 50,000 · Balance 50,000 F1: The option vests in four equal quarterly installments beginning on January 1, 2025. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.33 · Expires 2035-08-19 | Direct | 50,000 |
Reported balance
After 2025-09-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-09-04 · Grant · Acquired 50,000 · Balance 50,000 F2: The option vests in four equal quarterly installments beginning on January 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal quarterly installments beginning on January 1, 2025.
F2: The option vests in four equal quarterly installments beginning on January 1, 2026.
Prairie Operating Co.
Report date December 23, 2021 · Filed January 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2021-12-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 30,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.65 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-12-23 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Options granted pursuant to incentive and award plans. 25% of the options vest when the common share VWAP computed over 30 consecutive trading days reaches $2.50, $3.00, $3.50 and $4.00. |
Filing footnotes · ownership attribution and instrument terms
F1: Options granted pursuant to incentive and award plans. 25% of the options vest when the common share VWAP computed over 30 consecutive trading days reaches $2.50, $3.00, $3.50 and $4.00.
Research Solutions, Inc.
Report date September 20, 2021 · Filed September 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 340,602 |
Reported balance
After 2021-09-20 transaction · row 1
1 source rowRow 1 · 2021-09-20 · Tax withholding · Disposed 5,710 · Balance 340,602 F1: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for D. Urban UTMA CA | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for G. Urban UTMA CA | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for L. Urban UTMA CA | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors.
SRAX, Inc.
Report date March 14, 2023 · Filed March 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock Purchase OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.44 | Direct | 300,000 |
Reported balance
After 2023-03-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-14 · Grant · Acquired 300,000 · Balance 300,000 F1: Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant"). F2: The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant").
F2: The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2018 Filed Feb 13, 2018 00:17 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 9,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-007429 · tv485747_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,735 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on February 8, 2019 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2019 until fully vested. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 22:11 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 5,300 | $1.21 | $6,413.00 |
DisclosureSEC source: 0001144204-17-065140 · tv482010_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,705 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| November 21, 2017 Filed Dec 1, 2017 17:26 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 8,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-061828 · tv480543_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,005 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 21, 2018 and 1/12th of the RSAs vest on the last day of each quarter beginning December 31, 2018 until fully vested. Read SEC document |
| September 20, 2017 Filed Sep 21, 2017 22:33 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 6,600 | $1.14 | $7,524.00 |
DisclosureSEC source: 0001144204-17-049116 · v475615_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,869 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 21:23 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 47,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-044803 · v473911_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,469 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on August 22, 2018 and 1/12th of the RSAs vest on the last day of each quarter beginning September 30, 2018 until fully vested. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 23:25 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 18,500 | $1.00 | $18,500.00 |
DisclosureSEC source: 0001144204-17-033700 · v469514_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,640 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:52 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 10,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-027699 · v467111_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,140 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on May 11, 2018 and 1/12th of the RSAs vest on the last day of each quarter beginning June 30, 2018 until fully vested. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:07 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 8,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-009807 · v459911_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,680 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on February 16, 2018 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2018 until fully vested. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 21:01 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 12,700 | $1.03 | $13,081.00 |
DisclosureSEC source: 0001144204-16-140957 · v455628_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,201 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| December 20, 2016 Filed Feb 17, 2017 20:02 UTC Amendment | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 12,700 | $1.03 | $13,081.00 |
DisclosureSEC source: 0001144204-17-009805 · v459977_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,201 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:01 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-16-136342 · v453861_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,901 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 21, 2017 and 1/12th of the RSAs vest on the last day of each quarter beginning December 31, 2017 until fully vested. Read SEC document |
| November 21, 2016 Filed Feb 17, 2017 19:59 UTC Amendment | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-009803 · v459978_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,901 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 21, 2017 and 1/12th of the RSAs vest on the last day of each quarter beginning December 31, 2017 until fully vested. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 22:45 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 11,508 | $1.04 | $11,968.32 |
DisclosureSEC source: 0001144204-16-124944 · v449241_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,901 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.